Collegium Pharmaceutical (COLL) Return on Equity: 2017-2024
Historic Return on Equity for Collegium Pharmaceutical (COLL) over the last 8 years, with Dec 2024 value amounting to 0.20%.
- Collegium Pharmaceutical's Return on Equity fell 16.00% to 0.23% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.23%, marking a year-over-year decrease of 16.00%. This contributed to the annual value of 0.20% for FY2024, which is 4.00% down from last year.
- Per Collegium Pharmaceutical's latest filing, its Return on Equity stood at 0.20% for FY2024, which was down 15.26% from 0.24% recorded in FY2023.
- In the past 5 years, Collegium Pharmaceutical's Return on Equity registered a high of 0.37% during FY2021, and its lowest value of -0.17% during FY2022.
- Over the past 3 years, Collegium Pharmaceutical's median Return on Equity value was 0.20% (recorded in 2024), while the average stood at 0.09%.
- Per our database at Business Quant, Collegium Pharmaceutical's Return on Equity soared by 45bps in 2020 and then tumbled by 54bps in 2022.
- Yearly analysis of 5 years shows Collegium Pharmaceutical's Return on Equity stood at 0.20% in 2020, then grew by 17bps to 0.37% in 2021, then crashed by 54bps to -0.17% in 2022, then surged by 40bps to 0.24% in 2023, then dropped by 4bps to 0.20% in 2024.